Northern Trust Corp Kronos Bio, Inc. Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
A detailed history of Northern Trust Corp transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 74,347 shares of KRON stock, worth $70,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,347
Previous 75,567
1.61%
Holding current value
$70,629
Previous $93,000
20.43%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding KRON
# of Institutions
56Shares Held
19.8MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.63 Million3.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.83 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.61MShares$1.53 Million0.03% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.37 Million0.1% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $53.9M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...